The global pharmaceutical market for ophthalmic non-steroidal anti-inflammatory drugs (NSAIDs) is substantial and growing, driven by an aging population and an increasing number of cataract surgeries worldwide . At the heart of this market lies Nepafenac, a potent prodrug that offers targeted ocular anti-inflammatory action. For procurement managers, distributors, and pharmaceutical developers, understanding the complete Nepafenac global buyers list—from finished dosage form buyers to bulk API (Active Pharmaceutical Ingredient) purchasers—is not just a matter of logistics; it is a strategic imperative for ensuring supply chain security, regulatory compliance, and competitive pricing. This comprehensive guide serves as your definitive resource for navigating the global Nepafenac market. We will provide a detailed breakdown…